GREY:ALEAF - Post by User
Comment by
mar82ison Aug 14, 2019 8:18pm
106 Views
Post# 30029647
RE:RE:RE:Everyone missed key message in conference call
RE:RE:RE:Everyone missed key message in conference call The other LPs didn’t fare to good in earnings mostly negative.. we didn’t do so bad and only getting better in my opinion..
What do ppl think about Charlotte webs results?
Charlotte’s Web (TSX: CWEB) - Q2/19 financials
Q2 revenue was US$25.0 mm
net income was US$2.2 or $0.02/share.
Cash and cash equivalents at the end of Q2 were US$51.4 mm.
and are on track in the next quarter to be at 100million
Just trying to compare where we are at compared to them. Thoughts!!
here are the others numbers::
Tilray Inc. (NASDAQ:TLRY) - Q2/19 financials
Q2 revenue was US$45.9 mm
net loss was US$35.1 mm or $0.36/share
Cash and cash equivalents at the end of Q2 were US$184.5 mm.
Acreage Holdings (CSE:ACRG.U) - Q2/19 financials
Q2 revenue was US$17.7 mm
adjusted net loss was US$17.1 mm or $0.36/share
Flower One (CSE: FONE) - Q2/19 financials
Q2 revenue was US$636 k
net income was US$19.1 mm or $0.10/share f.d. (net income was positively impacted by an
unrealized fair value adjustment on growth of biological assets of $37.2 mm).
Cash at the end of the quarter was US$600k
[Editors Note: $600K in cash left?! Looks like they will have to tap their sugar daddy Canopy for a re-up unless they’re cleared to reach out to capital markets on their own...this deal is looking more like a bad one for investors every quarter…]
Flower One (CSE: FONE) - Q2/19 financials
Q2 revenue was US$636 k
net income was US$19.1 mm or $0.10/share f.d. (net income was positively impacted by an
unrealized fair value adjustment on growth of biological assets of $37.2 mm).
Cash at the end of the quarter was US$600k
[Editor’s Note: “Biological Assets” reporting is one of the biggest failures of financial reporting standards in the cannabis business - creating the impression of profit where none was had. When earnings are positive because of biological assets, discount the biological assets to 10 percent of the number to get a more authentic picture of what that should represent in the assets column of the company]
Charlotte’s Web (TSX: CWEB) - Q2/19 financials
Q2 revenue was US$25.0 mm
net income was US$2.2 or $0.02/share.
Cash and cash equivalents at the end of Q2 were US$51.4 mm.
[Editor’s Note: This is Charlotte’s Web solidly on track for a $100 million exit run rate for fiscal 2019...probably one of the top ten stories in the industry!]
Aleafia Health Inc. (TSX:ALEF) - Q2/19 financials
Q2 net revenue was $3.8 mm,
net loss was -$11.5 mm or -$0.04/share.
Cash and cash equivalents at the end of Q2 were $57.9 mm.
Zenabis Global Inc. (TSX: ZENA) - Q2/19 financials
Q2 net revenue was $25.0 mm,
net loss was $18.5 mm or $0.09/share.
Cash and cash equivalents at the end of Q2 were $8.7 mm.
Neptune Wellness (TSX: NEPT) - Q1/20 financials
revenue was $4.4 mm
net loss was $6.5 mm or $0.07/share.
Cash and cash equivalents were $5.4 million as of June 30, 2019.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) - Q2/19 financials
Q2 revenue was $2.9 mm
net loss was -$16.6 mm
-$0.06/share.
Cash and restricted cash at the end of Q2 were $122.7 mm.
Sundial Growers Inc. (NASDAQ: SNDL) - Q2/19 financials
Q2 net revenue was $19.3 mm
net loss was -$12.4 mm or -$0.16/share.